AAOS: Supplement Use Low in Patients With Osteoporosis, Hip Fracture
FRIDAY, March 15, 2019 -- Of patients diagnosed with osteoporosis who have a history of hip fracture, only 14 percent are receiving appropriate calcium and vitamin D supplementation, ac
FDA Approves a New Generic Diovan (valsartan)
March 12, 2019 -- Today, the U.S. Food and Drug Administration approved a new generic of Diovan(valsartan). Valsartan is an angiotensin II receptor blocker (ARB) that treats high blood pressure and heart fail
FDA Approves Rocklatan
FDA Approves Rocklatan (netarsudil and latanoprost ophthalmic solution) for the Reduction of Intraocular Pressure in Open-Angle Glaucoma or Ocular Hypertension
DURHAM, N.C.--(BUSINESS WIRE)--Mar. 12, 2019-- Aerie Pharmaceuticals
-- While energy drinks are promoted as products that increase energy and enhance performance, they also can put users at risk.
From 2007 to 2011, energy-drink related emergency room visits doubled. Overconsumption of energy drinks can cause a host of i
FDA Approves Spravato (esketamine) Nasal Spray for Treatment-Resistant Depression
March 5, 2019 -- The U.S. Food and Drug Administration today approved Spravato (esketamine) nasal spray, in conjunction with an oral antidepressant, for the treatment of de